Biocardia reports 2020 financial results and recent business highlights

San carlos, calif., march 30, 2021 (globe newswire) -- biocardia®, inc. [nasdaq: bcda], a leader in the development of comprehensive solutions for cardiovascular and pulmonary regenerative therapies, today reported financial results for the fourth quarter and full year ended december 31, 2020 and recent business highlights. biocardia has filed its annual 10-k with the securities and exchange commission.
BCDA Ratings Summary
BCDA Quant Ranking